Interestingly, anti–PD-1 Ab did not affect MAP before or 3 weeks after Aldo-salt administration, but it exacerbated Aldo-salt–induced hypertension 7 weeks after Aldo-salt administration (Figure 10I). The gene discussed is PDCD1; the disease is hypertensive disorder.